Vascular Injury Shunt

The U.S. Air Force seeks to commercialize through patent licensing a trauma specific vascular injury shunt to restore blood flow to an injured extremity until definitive vascular repair can be accomplished. The Technology: The U.S. Air Force has developed a trauma-specific vascular injury shunt (TS-VIS), which represents a breakthrough in the management of extremity vascular injury. The device has been designed by combat surgeons and military researchers to allow this capability to be applied in different operational environments including civilian and wartime. Its features also minimize the risk of complications, ensure its adapability to the unique needs of patients, and allow infusion of therapeutic (i.e. therapeutic reperfusion) or contrast agents (i.e. angiography) into the injured limb. Benefits: Safe: Designed for convenient, rapid insertion by broad range of surgeons and to lessen complication risks. Effective: Early reperfusion of damaged extremity leads to improved functional outcomes for patients. Game-Changing: First shunt designed for extremity vascular injury. Status and Opportunity: Provisional patent filed. Systematic preclinical studies published in peer-reviewed journals have demonstrated efficacy and safety of early restoration of extremity perfusion using this technique. Preparing for early prototype device preclinical studies. Licensing and commercialization/development partner(s) sought.